Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 30,351 | $8.07 | $244,932.57 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 4 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,153,857 F4 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 16, 2024. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
GrantCommon Stock | 84,839 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,184,208 F3 · shares: Consists of RSUs fully vested at the time of grant. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
GrantCommon Stock | 495,662 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,099,369 F2 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Issuer's Board of Directors (the "Board"), subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the RSU vest prior to February 16, 2025. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
PurchaseCommon Stock | 61,725 | $8.07 | $498,299.75 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 603,707 F1 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $7.84 to $8.20. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:15 UTC |
Lamberti FrankChief Operating Officer
|
Tax withholdingCommon Stock | 1,162 | $11.63 | $13,514.06 |
DisclosureSEC source: 0000950170-24-013429 · ownership.xml · nonDerivative · entry 2 Lamberti Frank · CIK 0001661501 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,460 F2 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of PSUs previously granted to the Reporting Person on February 19, 2021. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:15 UTC |
Lamberti FrankChief Operating Officer
|
GrantCommon Stock | 2,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-013429 · ownership.xml · nonDerivative · entry 1 Lamberti Frank · CIK 0001661501 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,622 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2021-2023 performance period. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:11 UTC |
Wang Henry CEVP, General Counsel
|
Tax withholdingCommon Stock | 1,430 | $11.63 | $16,630.90 |
DisclosureSEC source: 0000950170-24-013418 · ownership.xml · nonDerivative · entry 2 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,650 F3 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of PSUs previously granted to the Reporting Person on February 19, 2021. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:11 UTC |
Wang Henry CEVP, General Counsel
|
GrantCommon Stock | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-013418 · ownership.xml · nonDerivative · entry 1 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,080 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2021-2023 performance period. F2 · balance_after: Balance includes shares purchased through the Issuer's Employee Stock Purchase Plan since the Reporting Person's last Form 4 filing on May 8, 2023. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:05 UTC |
Amezquita AlexanderChief Financial Officer
|
Tax withholdingCommon Stock | 1,081 | $11.63 | $12,572.03 |
DisclosureSEC source: 0000950170-24-013413 · ownership.xml · nonDerivative · entry 2 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,411 F2 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of PSUs previously granted to the Reporting Person on February 19, 2021 and March 3, 2021. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:05 UTC |
Amezquita AlexanderChief Financial Officer
|
GrantCommon Stock | 2,635 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-013413 · ownership.xml · nonDerivative · entry 1 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,492 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2021-2023 performance period. Read SEC document |
| December 22, 2023 Filed Dec 27, 2023 23:55 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 79,100 | $15.07 | $1,192,037.00 |
DisclosureSEC source: 0001209191-23-059828 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,982 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on December 22, 2022. Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 23:03 UTC |
Amezquita AlexanderChief Financial Officer
|
Tax withholdingCommon Stock | 1,263 | $12.95 | $16,355.85 |
DisclosureSEC source: 0001209191-23-055219 · doc4.xml · nonDerivative · entry 1 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,857 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on November 9, 2020. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 23:10 UTC |
Macadrai RodicaDirector
|
GrantCommon Stock | 7,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054573 · doc4.xml · nonDerivative · entry 1 Macadrai Rodica · CIK 0001993942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,541 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 23:04 UTC |
Montesino IbelisEVP & Chief of Staff
|
Tax withholdingCommon Stock | 985 | $13.89 | $13,681.65 |
DisclosureSEC source: 0001209191-23-054569 · doc4.xml · nonDerivative · entry 1 Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,239 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on November 2, 2022. Read SEC document |
| August 30, 2023 Filed Aug 30, 2023 22:38 UTC |
Montesino IbelisEVP & Chief of Staff
|
SaleCommon Stock | 6,604 | $14.99 | $98,993.96 |
DisclosureSEC source: 0001209191-23-047779 · doc4.xml · nonDerivative · entry 2 Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,224 F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021. Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 22:38 UTC |
Montesino IbelisEVP & Chief of Staff
|
Tax withholdingCommon Stock | 3,492 | $15.47 | $54,021.24 |
DisclosureSEC source: 0001209191-23-047779 · doc4.xml · nonDerivative · entry 1 Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,828 F1 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person on August 28, 2020. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 23:29 UTC |
Montesino IbelisEVP & Chief of Staff
|
GrantStock Appreciation Rights · Derivative | 30,068 | $0.00 Strike: $18.61 | $0.00 |
DisclosureSEC source: 0001209191-23-045094 · doc4.xml · derivative · entry 2 Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,068 Underlying: Common Stock · 30,068 shares Expires 2033-08-04 F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of August 4, 2024, August 4, 2025, and August 4, 2026, subject to continued service through such date. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 23:29 UTC |
Montesino IbelisEVP & Chief of Staff
|
GrantCommon Stock | 4,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045094 · doc4.xml · nonDerivative · entry 1 Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,320 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of August 4, 2024, August 4, 2025, and August 4, 2026, subject to continued service through such date. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 23:25 UTC |
Lamberti FrankChief Operating Officer
|
GrantStock Appreciation Rights · Derivative | 64,432 | $0.00 Strike: $18.61 | $0.00 |
DisclosureSEC source: 0001209191-23-045092 · doc4.xml · derivative · entry 2 Lamberti Frank · CIK 0001661501 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,432 Underlying: Common Stock · 64,432 shares Expires 2033-08-04 F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of August 4, 2024, August 4, 2025, and August 4, 2026, subject to continued service through such date. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 23:25 UTC |
Lamberti FrankChief Operating Officer
|
GrantCommon Stock | 10,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045092 · doc4.xml · nonDerivative · entry 1 Lamberti Frank · CIK 0001661501 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,788 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of August 4, 2024, August 4, 2025, and August 4, 2026, subject to continued service through such date. Read SEC document |
| May 08, 2023 Filed May 10, 2023 21:20 UTC |
Gratziani Stephan PauloDirector
|
PurchaseCommon Stock | 23,500 | $14.06 | $330,299.55 |
DisclosureSEC source: 0001209191-23-028517 · doc4.xml · nonDerivative · entry 1 Gratziani Stephan Paulo · CIK 0001976128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,529 F1 · price: This transaction was executed in multiple trades at prices ranging from $14.02 to $14.06. The price reported reflects the weighted average purchase price of $14.0553. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:10 UTC |
L'Helias SophieDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028063 · doc4.xml · nonDerivative · entry 1 L'Helias Sophie · CIK 0001849394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,089 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:42 UTC |
Wang Henry CEVP, General Counsel
|
GrantStock Appreciation Rights · Derivative | 172,413 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001209191-23-028097 · doc4.xml · derivative · entry 2 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,413 Underlying: Common Stock · 172,413 shares Expires 2033-05-04 F3 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:42 UTC |
Wang Henry CEVP, General Counsel
|
GrantCommon Stock | 25,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028097 · doc4.xml · nonDerivative · entry 1 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,471 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. F2 · balance_after: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:38 UTC |
Lamberti FrankRegional Pres. Americas
|
GrantStock Appreciation Rights · Derivative | 80,049 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001209191-23-028091 · doc4.xml · derivative · entry 2 Lamberti Frank · CIK 0001661501 · Regional Pres. Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,049 Underlying: Common Stock · 80,049 shares Expires 2033-05-04 F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:38 UTC |
Lamberti FrankRegional Pres. Americas
|
GrantCommon Stock | 11,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028091 · doc4.xml · nonDerivative · entry 1 Lamberti Frank · CIK 0001661501 · Regional Pres. Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,713 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:36 UTC |
Irani Jehangir DSVP, PAO
|
GrantCommon Stock | 22,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028086 · doc4.xml · nonDerivative · entry 1 Irani Jehangir D · CIK 0001775818 · SVP, PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,669 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:33 UTC |
Hienrich EdiRegional Pres. EMEA & India
|
GrantStock Appreciation Rights · Derivative | 80,049 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001209191-23-028081 · doc4.xml · derivative · entry 3 Hienrich Edi · CIK 0001472187 · Regional Pres. EMEA & India 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,049 Underlying: Common Stock · 80,049 shares Expires 2033-05-04 F3 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:33 UTC |
Hienrich EdiRegional Pres. EMEA & India
|
GrantCommon Stock | 16,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028081 · doc4.xml · nonDerivative · entry 2 Hienrich Edi · CIK 0001472187 · Regional Pres. EMEA & India 10b5-1 filing: No plan indicated Ownership: Indirect · By wife Disclosed balance after: 34,361 F2 · shares: Consists of RSUs granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:33 UTC |
Hienrich EdiRegional Pres. EMEA & India
|
GrantCommon Stock | 11,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028081 · doc4.xml · nonDerivative · entry 1 Hienrich Edi · CIK 0001472187 · Regional Pres. EMEA & India 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,809 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:29 UTC |
Conchie StephenRegional Pres. APAC & China
|
GrantCommon Stock | 27,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028076 · doc4.xml · nonDerivative · entry 1 Conchie Stephen · CIK 0001661500 · Regional Pres. APAC & China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,793 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:26 UTC |
Amezquita AlexanderChief Financial Officer
|
GrantStock Appreciation Rights · Derivative | 172,413 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001209191-23-028074 · doc4.xml · derivative · entry 2 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,413 Underlying: Common Stock · 172,413 shares Expires 2033-05-04 F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:26 UTC |
Amezquita AlexanderChief Financial Officer
|
GrantCommon Stock | 25,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028074 · doc4.xml · nonDerivative · entry 1 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,120 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 4, 2024, May 4, 2025, and May 4, 2026, subject to continued service through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:23 UTC |
Otero MariaDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028072 · doc4.xml · nonDerivative · entry 1 Otero Maria · CIK 0001594205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,536 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:19 UTC |
Mulligan Donal LDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028070 · doc4.xml · nonDerivative · entry 1 Mulligan Donal L · CIK 0001406019 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,589 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:16 UTC |
Mendoza Juan MiguelDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028068 · doc4.xml · nonDerivative · entry 1 Mendoza Juan Miguel · CIK 0001738284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,622 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:13 UTC |
LeFevre Alan WDirector
|
GrantCommon Stock | 12,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028066 · doc4.xml · nonDerivative · entry 1 LeFevre Alan W · CIK 0001610428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,851 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:07 UTC |
Jones Kevin M.Director
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028061 · doc4.xml · nonDerivative · entry 1 Jones Kevin M. · CIK 0001815320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,589 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:03 UTC |
Carmona Richard HDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028058 · doc4.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,252 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 22:01 UTC |
Del Genes CelineDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028056 · doc4.xml · nonDerivative · entry 1 Del Genes Celine · CIK 0001926601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,416 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 21:56 UTC |
Gratziani Stephan PauloDirector
|
GrantCommon Stock | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028042 · doc4.xml · nonDerivative · entry 1 Gratziani Stephan Paulo · CIK 0001976128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,029 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| April 07, 2023 Filed Apr 11, 2023 21:14 UTC |
Schissel Mark JChief Operating Officer
|
Tax withholdingCommon Stock | 19,089 | $15.67 | $299,124.63 |
DisclosureSEC source: 0001209191-23-024030 · doc4.xml · nonDerivative · entry 1 Schissel Mark J · CIK 0001713270 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,090 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on April 7, 2020. Read SEC document |
| April 07, 2023 Filed Apr 11, 2023 21:12 UTC |
Lamberti FrankRegional Pres. Americas
|
Tax withholdingCommon Stock | 18,975 | $15.67 | $297,338.25 |
DisclosureSEC source: 0001209191-23-024028 · doc4.xml · nonDerivative · entry 1 Lamberti Frank · CIK 0001661501 · Regional Pres. Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,765 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on April 7, 2020. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:51 UTC |
Amezquita AlexanderChief Financial Officer
|
Tax withholdingCommon Stock | 38 | $20.62 | $783.56 |
DisclosureSEC source: 0001209191-23-016803 · doc4.xml · nonDerivative · entry 1 Amezquita Alexander · CIK 0001721325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,385 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on March 3, 2021. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 23:26 UTC |
Hienrich EdiRegional Pres. EMEA & India
|
Tax withholdingCommon Stock | 590 | $19.48 | $11,493.20 |
DisclosureSEC source: 0001209191-23-013863 · doc4.xml · nonDerivative · entry 2 Hienrich Edi · CIK 0001472187 · Regional Pres. EMEA & India 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 17,450 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person's Wife on February 25, 2022. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 23:26 UTC |
Hienrich EdiRegional Pres. EMEA & India
|
Tax withholdingCommon Stock | 1,284 | $19.48 | $25,012.32 |
DisclosureSEC source: 0001209191-23-013863 · doc4.xml · nonDerivative · entry 1 Hienrich Edi · CIK 0001472187 · Regional Pres. EMEA & India 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,861 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on February 25, 2022. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 23:22 UTC |
Irani Jehangir DSVP, PAO
|
Tax withholdingCommon Stock | 470 | $19.48 | $9,155.60 |
DisclosureSEC source: 0001209191-23-013853 · doc4.xml · nonDerivative · entry 1 Irani Jehangir D · CIK 0001775818 · SVP, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,611 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on February 25, 2022. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 23:20 UTC |
Lamberti FrankRegional Pres. Americas
|
Tax withholdingCommon Stock | 307 | $19.48 | $5,980.36 |
DisclosureSEC source: 0001209191-23-013849 · doc4.xml · nonDerivative · entry 1 Lamberti Frank · CIK 0001661501 · Regional Pres. Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,740 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on February 25, 2022. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 23:16 UTC |
Schissel Mark JChief Operating Officer
|
Tax withholdingCommon Stock | 520 | $19.48 | $10,129.60 |
DisclosureSEC source: 0001209191-23-013842 · doc4.xml · nonDerivative · entry 1 Schissel Mark J · CIK 0001713270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,179 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on February 25, 2022. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 23:01 UTC |
Wang Henry CEVP, General Counsel
|
Tax withholdingCommon Stock | 520 | $19.48 | $10,129.60 |
DisclosureSEC source: 0001209191-23-013828 · doc4.xml · nonDerivative · entry 1 Wang Henry C · CIK 0001738879 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,182 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units ("RSUs") previously granted to the Reporting Person on February 25, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.